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Once developed, end-stage renal disease cannot be reversed
by any current therapy. Bone morphogenetic protein-7
(BMP-7), however, is a possible treatment for reversing
end-stage renal disease. Previously, we showed that the BMP
antagonist uterine sensitization-associated gene-1 (USAG-1,
also known as ectodin and sclerostin domain-containing 1)
negatively regulates the renoprotective action of BMP-7.
Here, we show that the ratio between USAG-1 and BMP-7
expression increased dramatically in the later stage of
kidney development, with USAG-1 expression
overlapping BMP-7 only in differentiated distal tubules.
Examination of USAG-1 expression in developing kidney
indicated that a mosaic of proximal and distal tubule
marker-positive cells reside side by side in the immature
nephron. This suggests that each cell controls its own fate for
becoming a proximal or distal tubule cell. In kidney injury
models, the ratio of USAG-1 to BMP-7 expression decreased
with kidney damage but increased after subsequent
kidney regeneration. Our study suggests that USAG-1
expression in a kidney biopsy could be useful in predicting
outcome.
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Bone morphogenetic proteins (BMPs) are phylogenetically
conserved signaling molecules that belong to the transform-
ing growth factor-b superfamily.1 Although these proteins
were first identified by their capacity to promote endochon-
dral bone formation, they are involved in the cascades of
body patterning and morphogenesis. Furthermore, BMPs
play important roles after birth in the pathophysiology of
several diseases, including osteoporosis, arthritis, pulmonary
hypertension, and kidney diseases.2
Bone morphogenetic protein-7 is a 35-kDa homodimeric
protein, and kidney is the major site of BMP-7 synthesis
during embryogenesis as well as in postnatal development.
BMP-7-deficient mice die shortly after birth due to severe
renal hypoplasia.3,4 Mutant kidneys suffer gradual cessation
of nephrogenesis, associated with a reduction in ureteric bud
branching and loss of metanephric mesenchyme, indicating
that BMP-7 is essential for survival and differentiation of
mesenchymal cells in kidney development.5 In postnatal life,
many developmental features are recapitulated during renal
injury, and BMP-7 has been shown to be important in both
preservation of kidney function and resistance to injury. For
example, BMP-7 inhibits tubular epithelial cell dedifferentia-
tion,6–10 mesenchyme transformation, and apoptosis stimu-
lated by various renal injuries, and has an anti-inflammatory
effect in models of both acute and chronic renal failure.11
The local activity of endogenous BMP-7 is controlled not
only by the precise regulation of its expression, but also by
certain classes of molecules that bind to BMP-7, acting
as positive12 or negative regulators of BMP-7 activity in
the kidney.2,13–15 BMP antagonists function through
direct association with BMP, thus inhibiting the binding of
BMP to its receptors, and define the boundaries of BMP
activity.
Recently, we found that the product of uterine sensitiza-
tion-associated gene-1 (USAG-1) acts as a kidney-specific
BMP antagonist, and that USAG-1 binds to and inhibits the
biological activity of BMP-7.16 We further demonstrated that
USAG-1-deficient mice are resistant to kidney injury, and
that USAG-1 is the central negative regulator of BMP
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function in the adult kidney.17 Because the interaction
between BMP-7 and USAG-1 seems to play critical roles in
the kidney, we analyzed the balance between USAG-1 and
BMP-7 expression in kidney injury and development, and
demonstrated the reciprocal relationship between USAG-1
and BMP-7 expression in kidney injury and development.
Close examination of USAG-1 expression in developing
kidneys further provided a clue to proximal–distal differen-
tiation mechanism of nephron by demonstrating the
possibility that each single cell in an immature nephron
controls its own fate to become proximal or distal tubule cell.
In addition, USAG-1 expression in the kidney biopsy could
be a powerful diagnostic tool to predict renal prognosis.
RESULTS
Generation of USAG-1þ /LacZ knock-in mice
To facilitate the temporal and spatial analyses of USAG-1
expression, we generated in-frame USAG-1þ /LacZ mice. In
our previous work, the nuclear lacZ reporter gene that was
knocked in17 proved unsuitable for signal detection. In this
work, the cytoplasmic lacZ reporter gene was used to replace
the open reading frame of USAG-1 and create a novel knock-
in allele (Figure 1a). While USAG-1þ /LacZ mice showed no
overt defects, USAG-1LacZ/LacZ mice presented the same teeth
phenotype as observed in the original USAG-1 mutants.17 In
situ hybridization (ISH) of a USAG-1 antisense probe to
whole embryos at E9.5 and adult kidney specimen confirmed
that lacZ staining in USAG-1þ /LacZ mice reflected authentic
USAG-1 gene expression (Figure 1d).
USAG-1 is expressed in distal tubules and overlaps with
BMP-7 in distal convoluted tubules
To further analyze the localization of USAG-1 expression in
the kidney, we used several well-characterized segment
markers. First, we clarified the segments in which well-
known segment markers are expressed (Figure 2a). Tamm
Horsfall glycoprotein (THP) was expressed in thick ascend-
ing limb. The calbindin D28K was expressed in distal
convoluted tubules (DCTs) and connecting tubules (CTs).
Using the antibody from Upstate, NaKATPase a-1 subunit
was strongly expressed in thick ascending limb, DCT, and CT.
AQP-1 was expressed in proximal tubules, descending thin
limb, and possibly in ascending thin limb, while AQP-2 was
expressed in the collecting ducts (CDs)18 and CTs as
reported.
Next, we analyzed the localization of USAG-1 in adult
kidneys using these markers, and demonstrated that all the
tubules expressing calbindin D28K or THP in the cortex
expressed USAG-1 (Figure 2b and c). In the outer medulla,
USAG-1 expression completely overlapped with THP
(Figure 2d) and NaKATPase (Figure 2e), but not with
AQP-2 (Figure 2f) or AQP-1 (Figure 2g). In addition, USAG-
1 expression in the cortex did not overlap with AQP-2
(Figure 2f) or AQP-1 (Figure 2g), except for CTs, which were
double positive for lacZ transcript and AQP-2 (data not
shown). In the inner medulla, USAG-1 expression was not
detected (Figure 1d). From these findings, we concluded that
USAG-1 is predominantly expressed in the distal tubules,
more specifically, in thick ascending limb, DCT, and CT in
adult kidneys.
For comparison, the expression of BMP-7 was determined
using BMP-7þ /LacZ mice, and the tubules expressing
calbindin D28K (Figure 2h) or AQP-2 (data not shown)
were positive for lacZ transcript, indicating that BMP-7
is expressed in DCT, CT, and CD as previously reported
(Figure 2a).11
USAG-1 emerges in developing nephrons and colocalizes
with BMP-7 only in differentiated tubules
Next, we examined the expression of USAG-1 and BMP-7 in
kidney development. The expression of USAG-1 increased
toward the later stage of development, and peaked at E17.5,
while BMP-7 was constantly expressed during kidney
development and decreased at perinatal period (Figure 3a).
As a result, the ratio between USAG-1 and BMP-7 expression
increased significantly toward the later stage of development
(Figure 3a). We also compared the ratio between other BMP
antagonists and BMP-7, and demonstrated that USAG-1 is
predominantly the major BMP antagonist during kidney
development (Figure 3a). At E13.5, USAG-1 expression was
almost absent (Figure 3b), while BMP-7 expression was
intensely expressed in ureteric buds, adjacent metanephric
mesenchyme, and part of comma-shaped body (Figure 3c).
At E15.5, USAG-1 expression was still absent in the comma-
shaped body, but was strongly detected in more differentiated
tubular epithelial cells in the medulla, in a pattern similar to
that of BMP-7, except for the expression in the podocyte
layers of the developing glomeruli, where USAG-1 expression
was absent (Figure 3b and c). Therefore, we conclude that
USAG-1 emerges in developing nephrons and colocalizes
with BMP-7 only in differentiated tubules (Figure 3d). We
also examined the expression of several segmental markers in
USAG-1-deficient kidney to determine whether the develop-
mental process is modified; however, we could not observe
any difference in the expression pattern of these markers
(data not shown).
Mosaicism of proximal tubule marker-positive cell and distal
tubule marker-positive cell in a single immature nephron
From E17.5 to the neonatal period, two patterns of USAG-1
expression were observed in the kidneys: a strong signal in
distal tubules (Figure 3b, arrowheads) and a weak, patchy
signal in the cortex (Figure 3b, arrows). To demonstrate that
both signals were not due to endogenous b-galactosidase
activity in the kidney, kidneys of wild-type mice were
subjected to lacZ staining and incubated for the same period
of time, but no signal was detected (Figure 3b).
We further analyzed the property of these signals with
segment markers, and found that the strong signal in
neonatal USAG-1þ /LacZ kidneys colocalized with THP and
NaKATPase (Figure 4a and b), but not with AQP-1 or AQP-2
(Figure 4c and d). Calbindin D28K was hardly detected in the
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immature nephron at this stage. On the other hand, only the
weak, patchy signal, but not the strong signal, colocalized
with the expression of the lectin-binding sites for Lotus
Tetragonolobus Agglutnin (LTA) (Figure 4e), the marker
for proximal tubules.19 NDRG1, the cytoplasmic protein
upregulated in several stress stimuli,20 is known to be
expressed in the proximal tubules and CDs in the kidney.21
The weak, patchy signal of lacZ staining also colocalized with
NDRG1 expression (Figure 4f), indicating that these tubules
with weak, patchy signal of lacZ staining possess proximal
tubule property, as well. AQP-1 was partially positive in the
descending part of weak, patchy blue tubules (Figure 4d),
possibly indicating that these tubules might have the
characteristics of proximal tubules and thin limbs of Henle.
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Figure 1 | Generation of USAG-1þ /LacZ knock-in mice by gene targeting. (a) Design of Sostdc1 (gene symbol for USAG-1) null allele
with concomitant replacement by LacZ. Light gray arrows depict the two exons; black arrows indicate the coding sequence. The homology
boxes used for bacterial homologous recombination (BHR) are depicted as white (hb50 and hb30). The entire coding sequence of Sostdc1
was replaced by LacZ/Neo, in a manner such that the initiating ATG of Sostdc1 became the ATG of LacZ. The reporter open reading frame
(ORF), LacZ, is followed by an SV40 polyadenylation signal and SV40-derived associated sequence31 (purple boxes), whereas, the Neo
ORF is followed by the mouse PGK polyadenylation signal and associated sequence32 (yellow boxes). All of these elements are standard
elements used by Velocigene.29 The replacement afforded into the Sostdc1 BAC by BHR is also translated in an identical manner into the
mouse genome during targeting. Therefore, all the features shown above are also those present in the modified Sostdc1 locus in the
targeted embryonic stem (ES) cells. (b) PCR genotyping of USAG-1þ /þ , USAG-1þ /LacZ, and USAG-1LacZ/LacZ littermates. (c) Real-time RT–PCR
analysis of USAG-1 mRNA in the kidneys of USAG-1þ /þ , USAG-1þ /LacZ, and USAG-1LacZ/LacZ littermates. Expression of USAG-1 was normalized to
that of GAPDH and expressed relative to that in USAG-1þ /þ mice. (d) ISH of whole embryo and adult kidney section revealed a similar
distribution of USAG-1 mRNA and lacZ transcripts. C, cortex; OM, outer medulla; IM, inner medulla; P, proximal tubule; G, glomerulus.
Bar¼ 100 mm.
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Figure 2 | USAG-1 and BMP-7 overlap in DCTs. (a) Schematic illustration demonstrating the expression of USAG-1, BMP-7, and other
segment markers in the nephron. USAG-1 is expressed in thick ascending limb (TAL), DCTs, and in CTs, while BMP-7 is expressed in DCT,
CT, and in CD. (b) Tubules positive for calbindin D28K are positive for LacZ transcripts in the kidneys of USAG-1þ /LacZ mice. G, glomerulus.
Bar¼ 100 mm. (c) Tubules positive for THP in the cortex are positive for LacZ transcripts in the kidneys of USAG-1þ /LacZ mice. (d) Tubules
positive for THP in the cortex and medulla are positive for LacZ transcripts in the kidneys of USAG-1þ /LacZ mice. OM, outer medulla. (e) Tubules
positive for NaKATPase in the cortex and medulla are positive for LacZ transcripts in the kidneys of USAG-1þ /LacZ mice. (f and g)
Tubules positive for AQP-2 (f) or AQP-1 (g) are negative for LacZ transcripts in the kidneys of USAG-1þ /LacZ mice. (h) Tubules positive
for calbindin D28K are positive for LacZ transcripts in the kidneys of BMP-7þ /LacZ mice. LacZ transcripts in the kidneys of BMP-7þ /LacZ mice
are also positive in CD and podocyte in glomeruli.
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Figure 3 | USAG-1 emerged in developing nephrons and colocalized with BMP-7 in differentiated tubules. (a) Expression of USAG-1
and ratio of USAG-1/BMP-7 expression increased in kidney development. Metanephric kidneys from five to six embryos at indicated time
points, and kidneys from seven neonates were collected and subjected to RNA extraction. Expression levels of USAG-1 and BMP-7 were
normalized to the expression of GAPDH and expressed relative to the expression level in the adult kidney. The ratio of USAG-1 and
other BMP antagonists to BMP-7 expression was determined as described (see Materials and Methods). (b and c) Localization of lacZ
transcripts in developing USAG-1þ /LacZ (b) and BMP-7þ /LacZ (c) kidneys. Expression of USAG-1/lacZ transcripts did not emerge in immature
nephrons, where BMP-7 facilitates differentiation, but was strong and overlapped with that of BMP-7 in the fully differentiated tubules
(arrowheads). Besides, the strong signal of USAG-1/lacZ transcripts in distal tubules (arrowhead), a weak, patchy signal was observed in the
neonatal kidneys (arrows). UB, ureteric bud; M, mesenchyme; C, comma-shaped body; G, glomerulus. Bar¼ 100mm. (d) Schematic illustration
demonstrating the expression of USAG-1 and BMP-7 during kidney development. USAG-1 expression was negative in the immature nephron,
where BMP-7 was strongly expressed and promoted differentiation. USAG-1 expression emerged in more differentiated tubules and
overlapped with that of BMP-7.
Kidney International (2008) 73, 181–191 185
M Tanaka et al.: Expression of BMP-7 and USAG-1 o r i g i n a l a r t i c l e
USAG-1+/LacZ mice Immunostaining
Distal marker
USAG-1
NaKATPase
DifferentiationProximal marker
Lectin-binding site for LTA
NDRG1
Cortex
D
is
ta
l t
ub
ul
e 
m
ar
ke
r
CD
 m
ar
ke
r
Pr
ox
im
al
 tu
bu
le
H
en
le
 lo
op
 m
ar
ke
r
Pr
ox
im
al
 tu
bu
le
 m
ar
ke
r
Overlay (pseudocolor)
186 Kidney International (2008) 73, 181–191
o r i g i n a l a r t i c l e M Tanaka et al.: Expression of BMP-7 and USAG-1
Close examination of these tubules further clarified that the
weak, patchy signal of lacZ staining and NDRG1 signals were
not overlapping in a single cell, but were complementary in
the single tubule (Figure 4g); therefore, the tubule in this area
was made up of two types of epithelial cells: those with distal
tubule property and those with proximal tubule property
(Figure 4h). To exclude the possibility that lacZ staining
quenches the fluorescence of other markers, immunostaining
of the serial sections was performed and demonstrated
similar results (data not shown).
Figure 4 | Mosaicism of proximal tubule marker-positive cell and distal tubule marker-positive cell in a single immature nephron.
(a) Strong (arrowheads) and weak, patchy signal of lacZ transcripts in neonatal USAG-1þ /LacZ kidneys colocalized with NaKATPase.
Bar¼ 100 mm. (b) Strong signal of lacZ transcripts in neonatal USAG-1þ /LacZ kidneys colocalized with THP. (c) LacZ transcripts in neonatal
USAG-1þ /LacZ kidneys did not colocalize with AQP-2. (d) AQP-1 was partially positive in the descending tubules with weak, patchy signal
of lacZ transcripts (arrow). (e) Weak, patchy signal of lacZ transcripts colocalized with lectin-binding sites for Lotus Tetragonolobus Agglutnin
(LTA). (f) Weak, patchy signal of lacZ transcripts colocalized with NDRG1. (g) Close examination of the overlapping areas demonstrated that the
weak, patchy signal of lacZ transcripts (arrows) was not overlapping with NDRG1 expression, but was complementary in a single tubule.
(h) Working hypothesis for proximal–distal differentiation mechanism of kidney tubules. Proximal tubule marker-positive cells (green) lie side
by side with distal tubule marker-positive cells (red) in a single immature nephron. It is postulated that each single cell possesses its cell fate to
become proximal or distal tubular cell.
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Figure 5 | Expression of USAG-1 decreased in tubular injury. (a) Expression of USAG-1 mRNA decreased in acute tubular injury.
Expression of USAG-1 and BMP-7 and the ratio between USAG-1 and BMP-7 expression during cisplatin nephrotoxicity (CN) were determined
by real-time RT–PCR. Expression of USAG-1 and BMP-7 was normalized to that of GAPDH and expressed relative to that in mice on day 0.
The ratio between USAG-1 and BMP-7 expression was determined by setting the standard curve with plasmids encoding each gene at
various concentrations and analyzing the copy number of each gene contained in kidney cDNA (see Results). N¼ 4–6 for each experiment.
(b–e) Representative histological findings (b), ISH of USAG-1 mRNA (c), and lacZ staining of the USAG-1þ /LacZ (d), and BMP-7þ /LacZ
(e) kidneys during CN. Bar¼ 100 mm.
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The ratio between USAG-1 and BMP-7 expression was
reduced in tubular injury and increased in tubular
regeneration
We also examined the expression of USAG-1 and BMP-7 in
kidney injury. Administration of cisplatin causes acute
tubular necrosis and apoptosis, leading to deterioration of
renal function. USAG-1 but not BMP-7 mRNA in the kidney
decreased at day 3 of cisplatin nephrotoxicity (Figure 5a).
ISH and lacZ staining demonstrated that USAG-1 expression
was significantly reduced at day 3 of cisplatin nephrotoxicity,
while the lacZ staining in BMP-7þ /LacZ mice was maintained
(Figure 5c–e). At day 0 of cisplatin nephrotoxicity, the
expression level of USAG-1 was much higher than that of
BMP-7, but at day 3, the ratio between USAG-1 and BMP-7
expression was significantly decreased, indicating that the
reduction of USAG-1 expression was more prominent than
that of BMP-7.
Next, we examined the expression of USAG-1 in the
kidney regeneration. Administration of folic acid (FA) to
mice causes intratubular crystallization, which results in
dilatation and degeneration of tubules, leading to transient
acute renal failure22 (Figure 6a). In contrast to the cisplatin
nephrotoxicity model, damaged tubular epithelial cells
proliferate and regenerate after several days, and renal
function returns to normal by day 14 (Figure 6a). Expression
of USAG-1 in this model decreased during tubular epithelial
damage (day 1), but increased markedly during proliferation
and regeneration of tubular epithelial cells (days 7–10), and
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returned to the basal level when redifferentiation of tubular
epithelial cells was completed (day 14), while the expression of
BMP-7 increased gradually after the initial dip at day 1 (Figure
6b). ISH and lacZ staining demonstrated that USAG-1 was
strongly detected in the irregularly lined regenerating tubular
epithelial cells at day 10 (Figure 6d and e, arrows), which
might account for the increase in USAG-1 expression at this
time point (Figure 6b). The ratio between USAG-1 and BMP-
7 expression was significantly increased during the regenera-
tion phase (Figure 6b). We also compared the ratio between
other BMP antagonists and BMP-7 in both kidney disease
models, and demonstrated that USAG-1 is predominantly the
major BMP antagonist during kidney injury (Figure S1).
USAG-1 as a predictive marker for renal prognosis
Because USAG-1 is a negative regulator of the renoprotective
action of BMP-7, we postulated that high expression of
USAG-1 in the kidney biopsy might predict poor renal
prognosis.
Because regenerating tubules and damaged tubules are
observed in the regenerating period (days 7–10) of FA
nephrotoxicity and might mimic the situation in the clinical
kidney biopsy specimen, we utilized the model and
performed kidney biopsy at day 7 and examined renal
function at day 14. Interestingly, the expression of USAG-1 in
kidney biopsy at day 7 correlated significantly with renal
function at day 14 (Figure 7), indicating the possibility that
USAG-1 could be a predictive marker of renal prognosis. We
also performed renal biopsies at days 1 and 10. As shown in
Figure S2, USAG-1 expression at day 10 (N¼ 4, regenerating
period) correlated well with future renal function at day 14,
while USAG-1 expression at day 1 (N¼ 8, tubular damage
period) did not. Therefore, we conclude that USAG-1
expression correlated well with future renal function when
tubular regeneration is observed.
DISCUSSION
USAG-1 colocalizes with BMP-7 only in differentiated tubules
in developing kidney
During kidney development, BMP-7, made by both meta-
nephric mesenchyme and tubular epithelial cells (Figure 3c),
is a facilitator of ureteric bud branching at low concentra-
tions, but an inhibitor of branching at high concentrations.23
The discrepancy is a part of a feedback mechanism
that allows ureteric buds to branch into ‘unpopulated’ areas
of mesenchyme, but not into areas already populated by
nephrons and other bud branches. USAG-1 expression did
not emerge in immature nephrons where BMP-7 facilitates
differentiation, but was strongly expressed and overlapped
with BMP-7 in fully differentiated tubules (Figure 3b and c).
We also demonstrated that USAG-1 expression is lower than
that of BMP-7 at E13.5, is comparable at E14.5 and E15.5,
and is much higher at E17.5 and in newborns (Figure 3a). In
addition, USAG-1 is the major BMP antagonist during
kidney development (Figure 3a). These data support the idea
that USAG-1 might function as a feedback mechanism for
BMP-7 activity during kidney development. However, no
developmental abnormality was observed in the kidney of
USAG-1-deficient mice,17 and some redundant factor might
overcome the lack of USAG-1 in the kidney of USAG-1-
deficient mice during development. Twisted gastrulation is
one candidate for the redundancy, because the expression
pattern is similar to that of USAG-1 and the expression level
is the second highest among BMP antagonists to USAG-1
(Figure 3a).
USAG-1 expression gives an insight into proximal–distal
differentiation mechanism of immature nephron
In spite of that USAG-1 expression was confined to distal
tubules in adult kidney, weak, patchy expression of USAG-1
in neonatal kidneys colocalized with proximal tubular
markers, such as lectin-binding site for Lotus Tetragonolobus
and NDRG1 in the cortex. NaKATPase, another distal tubule
marker, also colocalized with proximal tubular markers in the
area (data not shown). AQP-1 was partially positive in the
descending part of weak, patchy blue tubules, possibly
indicating that these tubules might also have the property
of proximal tubules and thin limbs of Henle. Close
examination of the area double positive for proximal and
distal markers further demonstrated that each single cell is
not double positive for these two markers, but two types of
cells positive for each marker intermingled with each other in
a single tubule (Figure 4g and h). Little is known about the
mechanism how uniform mesenchymal cells differentiate to a
variety of cells, including glomerular epithelial cells, proximal
tubular cells, and distal tubular cells, along the proximal–dis-
tal axis.24 There has been a controversy between the following
two hypotheses: gradient of growth factors brings the
proximal–distal differentiation, or cell fate is determined for
each cell. Recent studies revealed critical roles of Notch in the
determination of proximal tubule cells and the fates of
podocytes.25–27 Our data might support the cell fate
0.4
n=23
rs=0.68706
P=0.00029
0.3
0.2
0.1
Se
ru
m
 c
re
at
in
in
e 
(da
y 1
4)
0
0 0.5
USAG-1/GAPDH (day 7)
1 1.5 2
Figure 7 | USAG-1 as a diagnostic marker for renal prognosis.
A significant correlation is observed between USAG-1 expression
in kidney biopsy sample at day 7 and serum creatinine at day 14
in FA nephrotoxicity (closed circle, N¼ 23). Open circles indicate control
kidneys without FA nephrotoxicity (N¼ 4).
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hypothesis because the proximal tubule marker-positive
cell lies side by side with the distal tubule marker-positive
cell in a single tubule (Figure 4g and h), and such chimeric
tubule could not be made by the gradient of growth factors.
From these findings, we postulate that each single cell
possesses its cell fate to become proximal tubular cell or distal
tubular cell. Further study is needed to clarify how these
chimeric tubules differentiate to mature tubules (Figure 4h).
Interestingly, all tubule epithelial cells positive for proximal
tubule marker reside in the chimeric tubules in neonatal
kidney, while some distal tubule marker-positive cells reside
outside the area and are terminally differentiated (Figure 4a
and c, arrowheads, H), indicating the possible sequence of
differentiation.
USAG-1 expression decreases in tubular injury and increases
in tubular regeneration
In the adult kidney, we demonstrated that the expression of
USAG-1 colocalized with BMP-7 in DCTs (Figure 2a) and
decreased in acute tubular injury (Figure 5). The reduction of
USAG-1 expression in renal injury is not simply due to loss
of tubular epithelial cells, because USAG-1 expression
decreased rapidly in the very early stage of diseases, when
morphological changes of tubular epithelial cells were not
obvious (data not shown).
During the recovery from renal failure, regeneration of
tubular epithelial cells occurs via proliferation and rediffer-
entiation of surviving renal cells.28 In the FA model, USAG-1
expression decreased during tubular injury, increased marked-
ly during the regeneration of surviving cells, and returned to
the basal level after redifferentiation was completed (Figure
6b). In contrast, the expression of BMP-7 increased gradually
to the basal level after the initial dip during tubular injury
(Figure 6b), resulting in a significant increase in the ratio
between USAG-1 and BMP-7 during regeneration. Further
examination with USAG-1-deficient mice is needed to clarify
the role of USAG-1 in the regeneration of kidney injury.
USAG-1 could be a diagnostic marker for renal prognosis
In the clinical setting, prediction of renal prognosis is difficult
even with histological examination, because damaged tubules
and regenerating tubules are mixed in the single specimen,
and are indistinguishable by morphology. Because USAG-1 is
a negative regulator of the renoprotective action of BMP-7,
we postulated that high expression of USAG-1 during kidney
diseases might be a sign of poor renal prognosis. Because the
coexistence of regenerating tubules and damaged tubules in
FA nephrotoxicity model resembles the situation of renal
biopsy in patients, we utilized the model and proved that
high expression of USAG-1 in kidney biopsy in regenerating
period correlated well with poor renal prognosis. Because the
expression of USAG-1 is confined to the kidney, serum
concentration of USAG-1 might reflect the renal expression
level of USAG-1. In that case, blood test for USAG-1
concentration might be enough to predict renal prognosis
and is suitable for health examination.
MATERIALS AND METHODS
Derivation of USAG-1/LacZ mice
To generate a null allele of Sostdc1 (gene symbol for USAG-1), the
coding sequence was replaced with the coding sequence of the
marker gene LacZ, using Velocigene technology, essentially as
described (Figure 1a).29 PCR genotyping was performed in all
subsequent studies to allow specific detection of the genotype (Figure
1b). The sequences of the primers used were as follows: primer A,
CCTTCTCTGTGTTTTCACTCCG; primer B, TGATTCAGGGTGCTG
TTGC; and lacZRev, CCGTAATGGGATAGGTCACG.
b-gal staining and in situ hybridization
b-gal staining and ISH were performed as described previously.17,29
Probe for ISH was designed to contain the open reading frame with
the following length and GC content: USAG-1, 1.0 kbp (GC 52.6%).
Hybridization was detected using an anti-DIG AP conjugate (Roche,
Basel, Switzerland) and NBT/BCIP solution (Roche).
Histological studies and immunostaining
The kidneys were fixed in Carnoy’s solution, embedded in paraffin,
and sections (4mm thick) were stained with periodic acid-Schiff for
routine histological examination. Frozen sections of the kidneys and
primary kidney tubular cells were immunostained as previously
described.30 Reagents utilized were anti-NaKATPase a-1 antibody
(Ab) (Upstate, Billerica, MA, USA), anti-calbindin D28K (Sigma,
St Louis, MO, USA), anti-Tamm Horsfall Protein Ab (Biomedical
Technologies Inc.), anti-aquaporin 1 Ab (Chemicon, Temecula, CA,
USA), anti-aquaporin 2 Ab (Calbiochem, Darmstadt, Germany),
FITC-conjugated lotus tetragonolobus agglutinin (LTA) (Sigma),
anti-LacZ Ab (Cappel, Solon, OH, USA), and anti-NDRG1 Ab.20
For double staining, immunostaining was performed before b-gal
staining, to avoid the possibility that the deposition of X-gal
interferes with antibody binding to the antigen.
Quantification of mRNA by real-time RT–PCR
Real-time reverse transcription (RT)–PCR was performed as
described previously.17 Specific primers were designed using Primer
Express software (Applied Biosystems, Foster City, CA, USA).
To compare the expression levels of different genes, we used modi-
fied real-time PCR by setting the standard curves with plasmids
encoding each gene at various concentrations, and analyzed the copy
number of each gene contained in kidney cDNA as previously
described.17 Serially diluted cDNA or plasmids were used to generate
the standard curve for each primer, and the PCR conditions were as
follows: 50 1C for 2 min, 95 1C for 10 min, then 95 1C for 15 s, and
60 1C for 1 min for 40 cycles.
Kidney disease models
Cisplatin nephrotoxicity was caused as described previously.17
Briefly, cisplatin (20 mg kg1, Sigma-Aldrich) was administered by
a single intraperitoneal injection to 8-week-old female C57BL/6J
mice (SLC Japan, Shizuoka, Japan). FA nephrotoxicity was caused by
a single intraperitoneal injection of FA (250 mg kg1, Sigma-
Aldrich) in 0.15 M NaHCO3 to 11-week-old male C57BL/6J mice.
The kidneys were collected at days 0, 1, 4, 10, and 14, with at least
three animals at each time point.
Animal use
All mice were housed in specific pathogen-free conditions. All animal
experiments were performed in accordance with the institutional
guidelines as well as the National Institutes of Health (NIH) guidelines.
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Statistical analysis
All assays were performed in triplicate. Data were presented as
mean7s.d. Statistical significance was assessed by analysis of
variance, followed by Fisher’s protected LSD post hoc test.
Correlation was determined by Spearman’s correlation analysis.
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SUPPLEMENTARY MATERIAL
Figure S1. Relative expression of USAG-1 and other BMP antagonists
to BMP-7 in kidney disease models.
Figure S2. Significant correlation was observed between USAG-1
expression and future serum creatinine (day 14) in case that kidney
biopsy was performed at day 10 but not at day 1 in folic acid
nephrotoxicity (closed circles).
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